Pharmabiz1h
DCGI calls for meeting with stakeholders of cosmetics industry to discuss issues
The Drugs Controller General of India (DCGI) will be meeting the stakeholders in the cosmetics industry in the country to discuss the issues relating to the regulatory provisions of the cosmetics ...
Pharmabiz1h
MoA working closely with WHO to develop IHP to set global efficacy standards for Ayush products: Ayush secretary
The Union Ministry of Ayush (MoA) is working closely with the World Health Organization (WHO) to develop an International Herbal Pharmacopoeia (IHP) to set global quality and efficacy standards for ...
Pharmabiz1h
PCI to award PMSPPS scholarship to eligible GPAT candidates
The Pharmacy Council of India (PCI) has informed all students who have qualified through Graduate Pharmacy Aptitude Test ...
Pharmabiz1h
Pharmacy college job fairs propel rapport between academia and industry to create capable workforce
Pharmacy college job fairs play a critical role in bridging the gap between academia and industry. The fair provides a platform for pharmaceutical companies to communicate their hiring needs directly ...
Pharmabiz11h
Sonoma Pharma receives US FDA 510(k) clearance for Microcyn-based wound care hydrogel
Sonoma Pharma receives US FDA 510(k) clearance for Microcyn-based wound care hydrogel: Boulder, Colorado Wednesday, November 13, 2024, 16:00 Hrs [IST] Sonoma Pharmaceuticals, Inc.
Pharmabiz15h
Abbisko announces positive results from phase 3 MANEUVER study of pimicotinib to treat tenosynovial giant cell tumour
Abbisko announces positive results from phase 3 MANEUVER study of pimicotinib to treat tenosynovial giant cell tumour: Shanghai Wednesday, November 13, 2024, 18:00 Hrs [IST] Abbis ...
Pharmabiz16h
Arch Biopartners doses first patient in Canada for phase II trial of LSALT peptide to treat cardiac surgery associated acute kidney injury
Arch Biopartners Inc, a late-stage clinical trial company focused on preventing inflammation and acute organ injury, has announced that patient recruitment and dosing have begun in Canada for the ...
Pharmabiz17h
Aethlon Medical reaches key milestone with enrollment of first patient in its Hemopurifier cancer trial in Australia
Aethlon Medical reaches key milestone with enrollment of first patient in its Hemopurifier cancer trial in Australia: San Diego Wednesday, November 13, 2024, 15:30 Hrs [IST] Aethl ...
Pharmabiz17h
Boehringer Ingelheim and MTM Vision join forces to combat vision loss from diabetes
Boehringer Ingelheim and the Mary Tyler Moore Vision Initiative (MTM Vision) jointly announce the start of a long-term collaboration as Boehringer becomes the first pharmaceutical company to join the ...
Pharmabiz18h
KOMET phase III trial of Koselugo shows statistically significant and clinically meaningful ORR vs. placebo in adults with neurofibromatosis type 1
KOMET phase III trial of Koselugo shows statistically significant and clinically meaningful ORR vs. placebo in adults with neurofibromatosis type 1: Cambridge, UK Wednesday, Novem ...
Pharmabiz19h
US FDA grants breakthrough therapy designation to Johnson & Johnson’s nipocalimab to treat adults living with moderate-to-severe Sjögren's disease
Spring House, Massachusetts Wednesday, November 13, 2024, 14:00 Hrs [IST] ...
Pharmabiz19h
Industry hails DoP's new scheme for strengthening of medical devices industry
The centrally sponsored scheme for strengthening of medical devices industry (SMDI), launched by the Central government last week, was widely welcomed by the medical devices industry in the country.